Question to the Department of Health and Social Care:

To ask His Majesty's Government, further to the Written Answer by Baroness Bloomfield of Hinton Waldrist on 3 October (HL2056), which new studies relating to the impact on children born from assisted reproductive technology treatments had led the expert Scientific and Clinical Advances Advisory Committee of the Human Fertilisation and Embryology Authority (HFEA) to consider new recommendations regarding (i) additional techniques with the aim of replacing mitochondria in embryos, (ii) genome editing of embryos that is not currently considered to be clinic-ready, and (iii) extending the 14-day limit for embryo research.

The Human Fertilisation and Embryology Authority has advised that its Scientific and Clinical Advances Advisory Committee has not made any specific new recommendations.